您的位置: 首页 > 2015年7月 第46卷 第4期 > 文字全文
2023年7月 第38卷 第7期11
目录

心脏体外循环手术前后HMGB1、CK、CK-MB、LDH、LD1、AST水平变化的研究

Study of heart extracorporeal circulation surgery on HMGB1 and CK and CK-MB and LDH and LD1 and AST levels

来源期刊: 广州医药 | 20-22 发布时间:2021-11-30 收稿时间:2025/11/13 16:44:32 阅读量:22
作者:
关键词:
体外循环缺血再灌注HMGB 1心肌酶炎症反应
Extracorporeal circulationIschemia reperfusionHMGB 1Cardiac enzymesInflammation
DOI:
10.3969/j.issn.1000-8535.2015.04.006
收稿时间:
2015-04-22 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探讨体外循环手术前后患者血清HMGB1、CK、CK-MB、LDH、LD1、AST水平变化及意义。方法 采用ELISA法检测57例体外循环患者手术前后血清HMGB1表达水平,采用临床常规方法检测血清中CK、CK-MB、LDH、LD1、AST水平。对体外循环手术前后血清HMGB1表达水平与CK、CK-MB、LDH、LD1、AST的水平进行比较与相关分析。结果 体外循环手术患者HMGB1、CK、CK-MB、LDH、LD1、AST水平在手术后0.5小时、24小时、48小时、72小时均高于手术前(P<0.05);HMGB1、CK、CK-MB、LD1、AST水平在手术后24小时达高峰,LDH水平高峰出现于手术后48小时,其他各指标渐渐下降。体外循环手术阻断时间延长,则HMGB1、CK、CK-MB、LDH、LD1、AST水平升高。体外循环手术后患者血清中HMGB1表达水平与CK、CK-MB、LDH、AST指标呈正相关关系(P<0.05)。结论 体外循环手术后患者血清HMGB1、CK、CK-MB、LDH、LD1、AST水平升高,HMGB1参与了心肌的缺血再灌注损伤过程。
Objective To investigate before extracorporeal circulation and after HMGB1, CK, CK-MB, LDH, LD1, AST levels and significance in serum of patients. Methods 57 cases before extracorporeal circulation surgery and after, the levels of HMGB1 were detected by ELISA,while the levels of CK and CK-MB and LDH and LD1 and AST were detected by using conventional methods of clinical. Difference of HMGB1 and CK, CK-MB, LDH, LD1 and AST levels were compared. The relationship were been analyzed on the patients before extracorporeal circulation surgery and after. Results In extracorporeal circulation surgery, HMGB1, CK, CK-MB, LDH, LD1, AST levels after surgery in 0.5 hours, 24 hours, 48 hours,72 hours were higher than before surgery (P<0.05); HMGB1, CK, CK-MB, LD1, AST levels peaked at 24 hours aftersurgery, LDH levels was peaked at 48 hours after surgery, and then gradually declined. Extracorporeal circulation blocking was prolonged, the levels of HMGB1 and CK and CK-MB and LDH and LD1 and AST were elevated. After extracorporeal circulation surgery in serum the levels of HMGB1 expression and CK,CK-MB,LDH, AST indicators showed a positive correlation(P<0.05). Conclusion The levels of HMGB1, CK, CK-MB, LDH, LD1 and AST were elevated after extracorporeal circulation surgery. HMGB1 was involved in myocardial ischemia and reperfusion injury.
1、 丁华胜,杨俊.高迁移率族蛋白B1在心肌缺血再灌注损伤中的研究进展[J]. 中国老年学杂志,2010,11(30):3408-3409. 丁华胜,杨俊.高迁移率族蛋白B1在心肌缺血再灌注损伤中的研究进展[J]. 中国老年学杂志,2010,11(30):3408-3409.
2、 庄俊华主编. 临床生化学检验技术[M].北京:人民卫生出版社,2009. 庄俊华主编. 临床生化学检验技术[M].北京:人民卫生出版社,2009.
3、 Hu X,Jiang H,Cui B, et al. Preconditioning with high mobility group box 1 protein protects against myocardial ischemia-reperfusion injury[J]. Int J Cardiol,2010,145(1):111-112. Hu X,Jiang H,Cui B, et al. Preconditioning with high mobility group box 1 protein protects against myocardial ischemia-reperfusion injury[J]. Int J Cardiol,2010,145(1):111-112.
4、 Andrassy M, Volz HC, Igwa JC, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart [J]. Circulation,2008,117(25):3216-3226. Andrassy M, Volz HC, Igwa JC, et al. High-mobility group box-1 in ischemia-reperfusion injury of the heart [J]. Circulation,2008,117(25):3216-3226.
5、 Federica L,Antonia G,Antonella Z,et al. Exogenous high-mobility groups box-1 protein induces myocardial regeneration after infarction via enhanced cardiac C-Kin+ cell proliferation and differentiation[J]. Circ Res,2005,97(8):73-83. Federica L,Antonia G,Antonella Z,et al. Exogenous high-mobility groups box-1 protein induces myocardial regeneration after infarction via enhanced cardiac C-Kin+ cell proliferation and differentiation[J]. Circ Res,2005,97(8):73-83.
6、 Roberta DM,Stefania S,Anna DC, et al. Multiple effects of high mobility group box-1 protein in skeletal muscle regeneration[J]. Arterioscler Thromb Vase Bilo,2007,27(11):2377-2383. Roberta DM,Stefania S,Anna DC, et al. Multiple effects of high mobility group box-1 protein in skeletal muscle regeneration[J]. Arterioscler Thromb Vase Bilo,2007,27(11):2377-2383.
7、 辛爱学,安美华,金鑫. 左卡尼汀联合曲美他嗪治疗缺血性心脏病患者的疗效观察[J]. 哈尔滨医药, 2012, 32(3):173-174. 辛爱学,安美华,金鑫. 左卡尼汀联合曲美他嗪治疗缺血性心脏病患者的疗效观察[J]. 哈尔滨医药, 2012, 32(3):173-174.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录